Lebenthal Global Advisors, LLC Bausch Health Companies Inc. Transaction History

Lebenthal Global Advisors, LLC

$540 Million
Q4 2024

A detailed history of Lebenthal Global Advisors, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Lebenthal Global Advisors, LLC holds 45,583 shares of BHC stock, worth $333,211. This represents 0.07% of its overall portfolio holdings.

Number of Shares

45,583

Previous 44,682 2.02%

Holding current value

$333,211

Previous $364,000 0.82%

% of portfolio

0.07%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$7.34 - $9.78 $6,613 - $8,811	901 Added 2.02%	45,583 $367,000
Q3 2024 Oct 28, 2024	BUY	$5.22 - $8.26 $882 - $1,395	169 Added 0.38%	44,682 $364,000
Q2 2024 Jul 24, 2024	BUY	$6.1 - $10.41 $170 - $291	28 Added 0.06%	44,513 $310,000
Q1 2024 May 09, 2024	SELL	$7.77 - $10.61 $103,900 - $141,876	-13,372 Reduced 23.11%	44,485 $471,000
Q4 2023 Feb 07, 2024	BUY	$6.53 - $8.23 $56,373 - $71,049	8,633 Added 17.54%	57,857 $464,000
Q3 2023 Nov 08, 2023	SELL	$7.69 - $9.71 $86,128 - $108,752	-11,200 Reduced 18.54%	49,224 $404,000
Q2 2023 Aug 08, 2023	SELL	$5.72 - $8.8 $93,539 - $143,906	-16,353 Reduced 21.3%	60,424 $483,000
Q1 2023 May 05, 2023	BUY	$6.28 - $9.85 $6,236 - $9,781	993 Added 1.31%	76,777 $621,000
Q4 2022 Feb 06, 2023	BUY	$6.09 - $7.93 $196,067 - $255,306	32,195 Added 73.86%	75,784 $475,000
Q3 2022 Nov 08, 2022	BUY	$4.58 - $9.21 $256 - $515	56 Added 0.13%	43,589 $300,000
Q2 2022 Aug 05, 2022	BUY	$7.06 - $23.63 $61,026 - $204,257	8,644 Added 24.78%	43,533 $363,000
Q1 2022 May 10, 2022	BUY	$21.6 - $27.79 $198,180 - $254,973	9,175 Added 35.68%	34,889 $797,000
Q4 2021 Apr 15, 2022	BUY	$23.0 - $29.01 $2,576 - $3,249	112 Added 0.44%	25,714 $709,000
Q4 2021 Feb 15, 2022	BUY	$23.0 - $29.01 $30,912 - $38,989	1,344 Added 5.54%	25,602 $706,000
Q3 2021 Nov 01, 2021	BUY	$25.04 - $30.06 $1,076 - $1,292	43 Added 0.18%	24,258 $675,000
Q2 2021 Aug 05, 2021	BUY	$27.43 - $32.7 $182,272 - $217,291	6,645 Added 37.82%	24,215 $710,000
Q1 2021 May 07, 2021	SELL	$21.37 - $34.38 $134,737 - $216,765	-6,305 Reduced 26.41%	17,570 $557,000
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $365,526 - $504,240	23,875 New	23,875 $494,000

Others Institutions Holding BHC

# of Institutions

270

Shares Held

252M

Call Options Held

5.12M

Put Options Held

9.43M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.64B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lebenthal Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lebenthal Global Advisors, LLC with notifications on news.

Account

Lebenthal Global Advisors, LLC Bausch Health Companies Inc. Transaction History